Work

Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination

Year: 2022

Type: article

Study design: Clinical Trial

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-022-03225-1

Authors: Ryan M. Kahn, Govind Ragupathi, Qin C. Zhou, Alexia Iasonos, Sara Kravetz, Martee L. Hensley, Jason A. Konner, Vicky Makker, William P. Tew, Carol Aghajanian, Paul J. Sabbatini, Roisin E. O’Cearbhaill

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Ollscoil na Gaillimhe – University of Galway

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National University of Ireland, Genentech, National Cancer Institute

Awards: G1229558712, G3684990230, G4102770861, G589551644, Cancer Center Support Grant

OpenAlex ID: W4283772524

FWCI: 0.856

Cites: 22

Cited by: 5

Related to: 10